American Century Companies’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
BCLSI
CAM
VCM
American Century Companies's CABA Position: Q1 2026 in Review
American Century Companies increased its Cabaletta Bio (CABA) stake by 84% in Q1 2026, buying an estimated $138K and bringing the position to 108,319 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #2644.
American Century Companies first reported a position in CABA in Q2 2023 and has held it in 4 quarters since. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.
- American Century Companies held 108,319 shares of Cabaletta Bio worth $291K as of Q1 2026.
- American Century Companies bought 49,542 Cabaletta Bio shares in Q1 2026, an estimated $138K.
- Cabaletta Bio made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2644 holding.
- American Century Companies first reported a position in Cabaletta Bio in Q2 2023 and has held it in 4 quarters since.
- 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.